Tavankit Singh
Overview
Explore the profile of Tavankit Singh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
256
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al Taani O, Al-Ajlouni Y, Jagdish B, Khataniar H, Aleyadeh W, Al-Bitar F, et al.
BMC Cancer
. 2024 Sep;
24(1):1098.
PMID: 39232707
Introduction: Liver cancer (LC) is frequently preceded by cirrhosis and poses a significant public health challenge in the United States (US). Recent decades have seen notable shifts in the epidemiological...
2.
Butt M, Karna R, Umar S, Chaturvedi A, Murali S, Singh T
Proc (Bayl Univ Med Cent)
. 2024 Aug;
37(5):769-773.
PMID: 39165822
Background: Statin therapy is widely utilized for preventing atherosclerotic cardiovascular disease, both as a primary and secondary measure. Despite the American Association for the Study of Liver Diseases' endorsement of...
3.
Aminian A, Al-Kurd A, Wilson R, Bena J, Fayazzadeh H, Singh T, et al.
JAMA
. 2021 Nov;
326(20):2031-2042.
PMID: 34762106
Importance: No therapy has been shown to reduce the risk of serious adverse outcomes in patients with nonalcoholic steatohepatitis (NASH). Objective: To investigate the long-term relationship between bariatric surgery and...
4.
Faisal M, Singh T, Amin H, Modaresi Esfeh J
J Fam Pract
. 2021 Aug;
70(4):174-181.
PMID: 34339360
Combined serum and ascites fluid measurements point to the cause of ascites. For patients with modest edema, a reduced weight-loss target with diuresis may be acceptable.
5.
Faisal M, Singh T, Amin H, Modaresi Esfeh J
World J Hepatol
. 2020 Nov;
12(10):880-882.
PMID: 33200025
Platelet-albumin-bilirubin (PALBI) score was proposed by Roayaie with modification of previously studied albumin-bilirubin score to include platelet as an indicator of portal hypertension in 2015. Predictive value of this score...
6.
Faisal M, Singh T, Modaresi Esfeh J
Dig Liver Dis
. 2020 Aug;
52(10):1213-1214.
PMID: 32778396
No abstract available.
7.
Vozzo C, Singh T, Bullen J, Sarvepalli S, McCullough A, Kapoor B
Gastroenterol Rep (Oxf)
. 2020 Apr;
8(2):98-103.
PMID: 32280469
Background: Placement of a transjugular intrahepatic portosystemic shunt (TIPS) is a relatively common procedure used to treat complications of portal hypertension. However, only limited data exist regarding the hospital-readmission rate...
8.
Alkhayyat M, Saleh M, Zmaili M, Sanghi V, Singh T, Rouphael C, et al.
World J Hepatol
. 2020 Apr;
12(3):108-115.
PMID: 32231764
Background: Sickle cell hepatopathy (SCH) is an inclusive term referring to any liver dysfunction among patients with sickle cell disease. Acute sickle cell intrahepatic cholestasis is one of the rarest...
9.
Singh T, Sanghi V, Thota P
Cleve Clin J Med
. 2020 Feb;
87(2):75-76.
PMID: 32015056
No abstract available.
10.
Rikhi R, Singh T, Modaresi Esfeh J
Ann Med Surg (Lond)
. 2020 Jan;
50:41-48.
PMID: 31993196
Nonalcoholic fatty liver disease (NAFLD) is an overarching term that refers to abnormal deposition of lipids in the liver and is used to describe the spectrum of disease ranging from...